1. Coyne, Alyssa N, Baskerville, Victoria, Zaepfel, Benjamin L, Lusk, C Patrick, Rothstein, Jeffrey D. . Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. In Science translational medicine, 13, . doi:10.1126/scitranslmed.abe1923. https://pubmed.ncbi.nlm.nih.gov/34321318/
2. Gatta, Alberto T, Olmos, Yolanda, Stoten, Caroline L, Rosenthal, Peter B, Carlton, Jeremy G. 2021. CDK1 controls CHMP7-dependent nuclear envelope reformation. In eLife, 10, . doi:10.7554/eLife.59999. https://pubmed.ncbi.nlm.nih.gov/34286694/
3. Al-Azzam, Norah, To, Jenny H, Gautam, Vaishali, Jovanovic, Marko, Yeo, Gene W. 2024. Inhibition of RNA splicing triggers CHMP7 nuclear entry, impacting TDP-43 function and leading to the onset of ALS cellular phenotypes. In Neuron, 112, 4033-4047.e8. doi:10.1016/j.neuron.2024.10.007. https://pubmed.ncbi.nlm.nih.gov/39486415/
4. Baskerville, Victoria, Rapuri, Sampath, Mehlhop, Emma, Coyne, Alyssa N. . SUN1 facilitates CHMP7 nuclear influx and injury cascades in sporadic amyotrophic lateral sclerosis. In Brain : a journal of neurology, 147, 109-121. doi:10.1093/brain/awad291. https://pubmed.ncbi.nlm.nih.gov/37639327/
5. Guo, Yu, Wang, Shu, Liang, Feng, Wang, Min. 2023. Identification of CHMP7 as a promising immunobiomarker for immunotherapy and chemotherapy and impact on prognosis of colorectal cancer patients. In Frontiers in cell and developmental biology, 11, 1211843. doi:10.3389/fcell.2023.1211843. https://pubmed.ncbi.nlm.nih.gov/37711849/